{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:07:28Z","timestamp":1788988048427,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cardfail.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:08:35Z","timestamp":1786115315000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Empagliflozin on Serum Calcium and Phosphate in Heart Failure"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"JO\u00c3O PEDRO","family":"FERREIRA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FAIEZ","family":"ZANNAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-0332","authenticated-orcid":false,"given":"GERASIMOS","family":"FILIPPATOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-5461","authenticated-orcid":false,"given":"PEDRO","family":"MARQUES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCISCO","family":"VASQUES-N\u00d3VOA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JO\u00c3O S\u00c9RGIO","family":"NEVES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUIS","family":"MENDON\u00c7A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAVED","family":"BUTLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFAN D.","family":"ANKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MILTON","family":"PACKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2026.07.026_bib0001","first-page":"3","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"34","author":"Civitelli","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/07853890701689645","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"40","author":"Renkema","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0003","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.ki.5002163","article-title":"Klotho: an antiaging protein involved in mineral and vitamin D metabolism","volume":"71","author":"Torres","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0272-6386(12)80977-2","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"23","author":"Slatopolsky","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40620-014-0075-y","article-title":"Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure","volume":"28","author":"Cubbon","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0006","article-title":"Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes: data from a randomized, placebo-controlled study","volume":"16","author":"Rau","year":"2022","journal-title":"Bone Rep"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0007","first-page":"e178","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease-mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1-3 chronic kidney disease","volume":"197","author":"Tsai","year":"2025","journal-title":"C M"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0008","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMc2112411","article-title":"Empagliflozin and major renal outcomes in heart failure","volume":"385","author":"Packer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0009","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ejhf.2065","article-title":"Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0011","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0012","article-title":"Serum magnesium and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced","volume":"14","author":"Ferreira","year":"2026","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0013","article-title":"Serum magnesium, outcomes, and the effect of empagliflozin in heart failure with mildly reduced and preserved ejection fraction: findings from EMPEROR-Preserved","volume":"14","author":"Ferreira","year":"2026","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0014","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0015","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1002\/ehf2.13024","article-title":"Empagliflozin inhibits Na(+) \/H(+) exchanger activity in human atrial cardiomyocytes","volume":"7","author":"Trum","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165729","article-title":"CaMKII and GLUT1 in heart failure and the role of gliflozins","volume":"1866","author":"Trum","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0017","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0018","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00395-024-01067-9","article-title":"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2","volume":"119","author":"Chen","year":"2024","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0019","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure\u2013a rational approach for disease treatment","volume":"21","author":"Gorski","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes","volume":"70","author":"Bers","year":"2008","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0021","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1113\/jphysiol.1975.sp011026","article-title":"Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells","volume":"249","author":"Fabiato","year":"1975","journal-title":"J Physiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0022","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2022.01.019","article-title":"Relationship of dapagliflozin with serum sodium: findings from the DAPA-HF trial","volume":"10","author":"Yeoh","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0023","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.3390\/ijms22157976","article-title":"Cardioprotection by SGLT2 inhibitors-does it all come down to Na(+)?","volume":"22","author":"Trum","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0024","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","article-title":"Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure","volume":"97","author":"Ai","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ehf2.12336","article-title":"Empagliflozin reduces Ca\/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes","volume":"5","author":"Mustroph","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0026","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12933-018-0790-0","article-title":"A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats","volume":"17","author":"Durak","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104781","article-title":"Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium","volume":"157","author":"Cappetta","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0028","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","article-title":"Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome","volume":"14","author":"Gotsman","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cardfail.2015.04.015","article-title":"Association of hypocalcemia with mortality in hospitalized patients with heart failure and chronic kidney disease","volume":"21","author":"Miura","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0030","first-page":"H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"263","author":"Schl\u00fcter","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0031","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0032","first-page":"H1998","article-title":"Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes","volume":"264","author":"Smogorzewski","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0033","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/j.2040-4603.2016.tb00690.x","article-title":"PTH and Vitamin D","volume":"6","author":"Khundmiri","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0034","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijcard.2016.09.014","article-title":"A low plasma 1,25(OH)(2) vitamin D\/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure","volume":"224","author":"Masson","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135427","article-title":"1,25-dihydroxyvitamin D to PTH(1-84) ratios strongly predict cardiovascular death in heart failure","volume":"10","author":"Gruson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0036","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"Wannamethee","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0037","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ndt\/gfad213","article-title":"Hypocalcemia and cardiovascular mortality in cinacalcet users","volume":"39","author":"Goto","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0038","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.amjms.2017.02.008","article-title":"Secondary hyperparathyroidism in heart failure","volume":"354","author":"Morsy","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0039","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ejhf.3348","article-title":"Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: an exploratory prospective substudy from HEART-FID","volume":"27","author":"Nouhravesh","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cardfail.2012.11.008","article-title":"Serum phosphate and long-term outcome among patients with stable heart failure","volume":"19","author":"Ess","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0041","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10741-017-9615-6","article-title":"Phosphate imbalance in patients with heart failure","volume":"22","author":"Christopoulou","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0042","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2026.07.026_bib0043","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ejhf.2409","article-title":"Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced","volume":"24","author":"Ferreira","year":"2021","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426004562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426004562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:17:13Z","timestamp":1788985033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916426004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S1071916426004562"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.07.026","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Empagliflozin on Serum Calcium and Phosphate in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}